Works matching IS 17562856 AND DT 2009 AND VI 2 AND IP 2

Results: 5
    1
    2

    Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 2, p. 67, doi. 10.1177/1756285608101379
    By:
    • Patti, Francesco;
    • Pia Amato, Maria;
    • Bastianello, Stefano;
    • Caniatti, Luisa;
    • Di Monte, Elisabetta;
    • Lijoi, Fausto;
    • Goretti, Benedetta;
    • Messina, Silvia;
    • Picconi, Orietta;
    • Tola, Maria Rosalia;
    • Trojano, Maria
    Publication type:
    Article
    3
    4

    Review: Primary CNS lymphoma.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2009, v. 2, n. 2, p. 93, doi. 10.1177/1756285608101222
    By:
    • Schlegel, Uwe
    Publication type:
    Article
    5